On‐Chip Self‐Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications

A hybrid nanocomposite comprised by porous silicon nanoparticles and a stimuli responsive polymeric material, polyethylene glycol-block-poly(L-histidine), is spontaneously formed by nanoprecipitation in a flow-focusing microfluidic chip. The nanocomposite presents a novel hybrid compound micelle structure with a great robustness for therapeutic applications. Therefore, the nanocomposite is developed and tested as a “smart” multistage drug delivery system (MDDS) in response to some of the current problems that cancer treatment presents. Based on the stimuli-responsive behavior of the nanocomposite, a chemotherapeutic agent is successfully loaded into the nanosystem and released upon changes in the pH-values. The nanocomposite demonstrates enhanced stability in plasma, narrow size distribution, improved surface smoothness, and high cytocompatibility. Furthermore, the nanocomposite presents reduced nanoparticle internalization by phagocytic macrophage cells and pH-dependent cell growth inhibition capacity. Overall, the developed hybrid nanocomposite shows very promising features for its further development as a “smart” pH-responsive MDDS.

[1]  Vladimir P Torchilin,et al.  pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. , 2013, Biomaterials.

[2]  Z. Fan,et al.  Theranostic Self-Assembly Structure of Gold Nanoparticles for NIR Photothermal Therapy and X-Ray Computed Tomography Imaging , 2014, Theranostics.

[3]  Hélder A Santos,et al.  Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy. , 2013, Biomaterials.

[4]  R. Müller,et al.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.

[5]  Shreyas S. Rao,et al.  Polylysine-Modified PEG-Based Hydrogels to Enhance the Neuro–Electrode Interface , 2011, Journal of biomaterials science. Polymer edition.

[6]  Ick Chan Kwon,et al.  Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links. , 2012, Biomaterials.

[7]  Jarno Salonen,et al.  Fabrication of a Multifunctional Nano‐in‐micro Drug Delivery Platform by Microfluidic Templated Encapsulation of Porous Silicon in Polymer Matrix , 2014, Advanced materials.

[8]  H. Santos,et al.  Multifunctional porous silicon for therapeutic drug delivery and imaging. , 2011, Current drug discovery technologies.

[9]  Vesa-Pekka Lehto,et al.  Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. , 2010, ACS nano.

[10]  You Han Bae,et al.  Super pH-sensitive multifunctional polymeric micelle. , 2005, Nano letters.

[11]  D. Weitz,et al.  Microfluidic assembly of multistage porous silicon-lipid vesicles for controlled drug release. , 2014, Lab on a chip.

[12]  W. Osiris,et al.  Reconstruction of resected mandibles using a hydroxyapatite veterinary bone graft. , 1994, Biomaterials.

[13]  J R Griffiths,et al.  Causes and consequences of tumour acidity and implications for treatment. , 2000, Molecular medicine today.

[14]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[15]  Vesa-Pekka Lehto,et al.  Microfluidic assembly of monodisperse multistage pH-responsive polymer/porous silicon composites for precisely controlled multi-drug delivery. , 2014, Small.

[16]  H. Santos,et al.  In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size. , 2010, Acta biomaterialia.

[17]  Stefan Tenzer,et al.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.

[18]  H. Santos,et al.  New times, new trends for ethionamide: In vitro evaluation of drug-loaded thermally carbonized porous silicon microparticles. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  H. Santos,et al.  Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution. , 2012, Molecular pharmaceutics.

[20]  Bruno Sarmento,et al.  The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium. , 2014, Biomaterials.

[21]  H. Santos,et al.  Surface chemistry dependent immunostimulative potential of porous silicon nanoplatforms. , 2014, Biomaterials.

[22]  Tianjiao Ji,et al.  Using Functional Nanomaterials to Target and Regulate the Tumor Microenvironment: Diagnostic and Therapeutic Applications , 2013, Advanced materials.

[23]  Patrick V. Almeida,et al.  Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors. , 2014, Nanoscale.

[24]  Vesa-Pekka Lehto,et al.  Fabrication and chemical surface modification of mesoporous silicon for biomedical applications , 2008 .

[25]  Eun Seong Lee,et al.  Physicochemical characteristics of pH-sensitive poly(L-histidine)-b-poly(ethylene glycol)/poly(L-lactide)-b-poly(ethylene glycol) mixed micelles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[26]  K. Audus,et al.  Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers. , 2002, Journal of pharmaceutical sciences.

[27]  Jarno Salonen,et al.  Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles. , 2012, International journal of pharmaceutics.

[28]  A. Eisenberg,et al.  Multiple Morphologies and Characteristics of “Crew-Cut” Micelle-like Aggregates of Polystyrene-b-poly(acrylic acid) Diblock Copolymers in Aqueous Solutions , 1996 .

[29]  H. Santos,et al.  Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers. , 2014, Biomaterials.

[30]  Robert Langer,et al.  Microfluidic platform for controlled synthesis of polymeric nanoparticles. , 2008, Nano letters.

[31]  Niklas Sandler,et al.  Microfluidic templated mesoporous silicon-solid lipid microcomposites for sustained drug delivery. , 2013, ACS applied materials & interfaces.

[32]  Leone Spiccia,et al.  Nanomaterials: Applications in Cancer Imaging and Therapy , 2011, Advanced materials.

[33]  Hélder A Santos,et al.  Copper-free azide-alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake. , 2014, Biomaterials.

[34]  Robert Langer,et al.  Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy , 2010, Proceedings of the National Academy of Sciences.

[35]  D W Hutmacher,et al.  Fabrication using a rapid prototyping system and in vitro characterization of PEG-PCL-PLA scaffolds for tissue engineering , 2005, Journal of biomaterials science. Polymer edition.

[36]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[37]  Hyun Joon Shin,et al.  Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Wolfgang J Parak,et al.  A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. , 2009, Nature nanotechnology.